MICROCAP DAILY - The Exciting Story of Puration Inc (OTCMKTS: PURA)
August 26 2020 - 9:02AM
InvestorsHub NewsWire
August 26, 2020 -- InvestorsHub NewsWire -- via Microcap Daily
--
BY ALEX
RYAN ON AUGUST 25, 2020MEDIA & TECHNOLOGY, MICRO CAP INSIDER, STREET WATCH
Puration Inc (OTCMKTS:
PURA) has been running up the chrarts in recent days after the
Company scheduled an earnings update as well as new information on
the company’s ongoing acquisition campaign to expand its CBD
infused consumer product reach. PURA reported $1.6 million in sales
year to date through Q2 2020. The company reported just shy of $1.1
million for the same period last year. PURA’s sales growth YTD
compared to the same period last year is 48%.
the stock has been on the move in recent days popping over the
$0.02 mark on a surge of volume. PURA has runner in its blood and
skyrocketed to highs of $0.25 back in 2018; a run that
microcapdaily reported on. PURA recently secured a $5 million
investment to fund its acquisition campaign in January, the company
has acquired a CBD confections business, a CBD pet products
business and CBD sun care business.
Puration Inc (OTCMKTS:
PURA) started off as a water purification company that began to
explore and develop new business opportunities focusing on the
emerging Cannabis Extractions Sector. The Company is now
emerging as aa leading Texas-based, CBD-infused beverage
provider. The Company is focused on growing the distribution
and sales of its product line both domestically and
internationally. Along these lines, the Company acquired a German
entity in December of 2019 to expand European distribution. During
the Quarter ending September 30, 2017, the Company announced the
acquisition of a 25-greenhouse grow operation located in East Texas
known as First Choice Nursery.
The Company launched its EVERx CBD Infused Sports Waters in the
spring of 2017 at Arnold Schwarzenegger’s Arnold Sports Festival.
EVERx has since become the leading CBD infused beverage in the
sports nutrition market place. The company’s sales grew 600% in the
first year after the launch of EVERx. Kiwi Strawberry and Lemon
Lime flavors are now available in addition to the Original EVERx
CBD Infused Sports Water.
EVERx has more than twice the CBD of most CBD infused waters on
the market. A proprietary technology enables EVERx to suspend
more CBD than its competitors and still have a crystal-clear
appearance and a refreshing taste. The company has recently
initiated a package redesign after extensive market testing of a
new logo design. Consumer demand for CBD infused beverages is
growing and Puration is likewise receiving inquiries from a broader
array of retail outlets. The package redesign is the first
step of a comprehensive marketing plan to dramatically increase
EVERx sales over the next 24 months.
On August 25 PURA reported it has exceeded $3 million in revenue
over the trailing 12 months. Last week, the company published its
Q2 2020 financials reporting $1.6 million in sales year-to-date
(YTD) representing 48% revenue growth compared to the same period
last year. Today, management is publishing a comprehensive update
that includes a review of the Q2 2020 report and the latest
information on a pending 1 for 1 dividend anticipated to be issued
soon to PURA shareholders in addition to new information on a
surprise second 1 for 1 dividend opportunity. The report also
includes the latest on the company’s ongoing acquisition campaign
to expand horizontally from its existing CBD infused beverage
market into an addition $500 billion market opportunity. The update
is included in its entirety below:
PURA remains resilient through the COVID-19 Pandemic reporting
48% sales growth YTD compared to the same period last year. The
company realized $1.6 million in revenue with $471,000 in gross
profit primarily from sales of its EVERx CBD Sports Water. PURA
expects to maintain resilient sales throughout the year. At the
same time the company continues to position itself as an overall
CBD infused consumer products company through its ongoing
acquisition campaign.
In January of this year, PURA initiated an acquisition campaign
to introduce a solution to the cannabis sector-wide challenge with
access to capital by leveraging its own core competencies to
acquire CBD infused beverage, edible and topical businesses. PURA
targets CBD product acquisitions that can be enhanced with PURA’s
patented technology. PURA owns a license to a U.S. Patented
cannabis extraction process backed by extensive university medical
research. The license, issued by NCM Biotech, is exclusive for
beverages, edibles and cosmetics among other uses. NCM Biotech is
focused on medical research and Puration has access to that
research. See a recent research report on CBD extracts derived from
NCM Biotech’s patented extraction process: Journal of Cannabis
Research.
Currently trading at a $19 million market valuation
PURA is an exciting story developing in small caps;
the Comapany is experiencing growth through acquisition recently
securing a $5 million investment to fund its acquisition campaign
which has already netted the Comapany a CBD confections business, a
CBD pet products business and CBD sun care business. On
August 25 PURA reported it has exceeded $3 million in revenue over
the trailing 12 months. Last week, the company published its Q2
2020 financials reporting $1.6 million in sales year-to-date (YTD)
representing 48% revenue growth compared to the same period last
year.We will be updating on PURA when more details emerge
so make sure you are subscribed to Microcapdaily so you know what’s
going on with PURA.
Other recent MICROCAP DAILY features include
GAXY,
CYDY and
SOAN
Disclosure: we hold no position in PURA either long or short and we
have not been compensated for this article.
Source: https://microcapdaily.com/the-exciting-story-of-puration-inc-otcmkts-pura/127518/
SOURCE: Microcap Daily
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Aug 2024 to Sep 2024
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Sep 2023 to Sep 2024